113 results

Richard Pops, chief executive  of Alkermes pictured in their Dublin offices in May 2012 following the EDT deal. Photo: Aidan Crawley

Alkermes, the US company that acquired Elan’s drug manufacturing business in Athlone, announced today that it will cut almost a third of the wo(...)

Robert Ingram, chairman of Elan with Kelly Martin, CEO. Photograph: David Sleator

Royalty Pharma must make an offer for Elan by May 10th or announce it will not proceed, the Irish Takeover Panel said yesterday. The deci(...)

Irish biopharma group Elan has closed a deal to transfer ownership of its multiple sclerosis drug Tysabri to US partner Biogen Idec in return f(...)

  • « First
  • Prev
  • 9
  • 10
  • 11
  • 12